Q2 2025 |
148 |
$2.61B |
+$140M |
-$191M |
-$51.6M |
META, MSFT, AVGO, TSLA, NFLX
|
13F-HR |
8/13/2025, 11:21 AM |
Q1 2025 |
146 |
$2.29B |
+$149M |
-$171M |
-$22.7M |
META, MSFT, AVGO, TSLA, NVDA
|
13F-HR |
5/12/2025, 11:46 AM |
Q4 2024 |
145 |
$2.45B |
+$173M |
-$129M |
+$44.5M |
META, AVGO, MSFT, TSLA, NVDA
|
13F-HR |
2/13/2025, 01:14 PM |
Q3 2024 |
141 |
$2.32B |
+$189M |
-$70.7M |
+$118M |
META, MSFT, AVGO, TSLA, NVDA
|
13F-HR |
11/13/2024, 12:57 PM |
Q2 2024 |
143 |
$2.17B |
+$183M |
-$113M |
+$69.9M |
MSFT, META, AVGO, NVDA, LLY
|
13F-HR |
8/13/2024, 10:08 AM |
Q1 2024 |
147 |
$2.09B |
+$218M |
-$279M |
-$60.3M |
MSFT, META, AVGO, LLY, NVDA
|
13F-HR |
5/14/2024, 04:20 PM |
Q4 2023 |
153 |
$1.95B |
+$78.5M |
-$90.5M |
-$12.1M |
MSFT, AVGO, META, TSLA, LLY
|
13F-HR |
2/13/2024, 02:40 PM |
Q3 2023 |
165 |
$1.74B |
+$85.6M |
-$75.1M |
+$10.5M |
MSFT, META, TSLA, AVGO, LLY
|
13F-HR |
11/13/2023, 01:37 PM |
Q2 2023 |
159 |
$1.78B |
+$95.6M |
-$97.8M |
-$2.21M |
MSFT, TSLA, META, AVGO, LLY
|
13F-HR |
8/11/2023, 12:20 PM |
Q1 2023 |
160 |
$1.67B |
+$154M |
-$39.4M |
+$115M |
MSFT, TSLA, META, AVGO, LLY
|
13F-HR |
5/15/2023, 11:41 AM |
Q4 2022 |
155 |
$1.45B |
+$91.7M |
-$88.5M |
+$3.23M |
MSFT, TSLA, LLY, AVGO, JPM
|
13F-HR |
2/14/2023, 12:53 PM |
Q3 2022 |
157 |
$1.43B |
+$323M |
-$21.8M |
+$301M |
TSLA, MSFT, META, AMZN, LLY
|
13F-HR |
11/14/2022, 10:57 AM |
Q2 2022 |
154 |
$1.33B |
+$117M |
-$88.6M |
+$28.6M |
TSLA, MSFT, META, GOOGL, AMZN
|
13F-HR |
8/15/2022, 12:00 PM |
Q1 2022 |
160 |
$1.76B |
+$144M |
-$136M |
+$7.79M |
TSLA, MSFT, META, AMZN, GOOGL
|
Restatement |
5/19/2022, 02:29 PM |
Q4 2021 |
157 |
$1.97B |
+$130M |
-$103M |
+$27.7M |
TSLA, MSFT, META, AMZN, GOOGL
|
13F-HR |
2/14/2022, 01:27 PM |
Q3 2021 |
155 |
$1.84B |
+$57.7M |
-$55.2M |
+$2.51M |
TSLA, MSFT, META, AMZN, PYPL
|
13F-HR |
11/15/2021, 12:30 PM |
Q2 2021 |
158 |
$1.82B |
+$125M |
-$120M |
+$5.66M |
TSLA, MSFT, META, AMZN, PYPL
|
13F-HR |
8/16/2021, 02:01 PM |
Q1 2021 |
155 |
$1.66B |
+$77.8M |
-$172M |
-$94.1M |
TSLA, MSFT, META, AMZN, JPM
|
13F-HR |
5/14/2021, 01:21 PM |
Q4 2020 |
159 |
$1.71B |
+$114M |
-$120M |
-$6.14M |
TSLA, AMZN, META, MSFT, TSM
|
13F-HR |
2/12/2021, 05:52 PM |
Q3 2020 |
153 |
$1.48B |
+$397M |
-$24.4M |
+$372M |
TSLA, AMZN, META, MSFT, MA
|
13F-HR |
11/13/2020, 12:19 PM |
Q2 2020 |
170 |
$1.07B |
+$44.6M |
-$103M |
-$58.1M |
AMZN, TSLA, MSFT, META, MA
|
13F-HR |
8/14/2020, 01:55 PM |
Q1 2020 |
176 |
$891M |
+$241M |
-$96.8M |
+$145M |
AMZN, MSFT, META, TSLA, MA
|
13F-HR |
5/15/2020, 04:21 PM |
Q4 2019 |
137 |
$949M |
+$263M |
-$14.2M |
+$249M |
MSFT, AMZN, META, AVGO, JPM
|
13F-HR |
2/18/2020, 01:54 PM |
Q3 2019 |
137 |
$661M |
+$255M |
-$12.8M |
+$243M |
AMZN, MSFT, META, CME, AVGO
|
13F-HR |
11/14/2019, 01:13 PM |
Q2 2019 |
136 |
$421M |
+$16.7M |
-$18.9M |
-$2.26M |
AMZN, AVGO, CME, MSFT, META
|
13F-HR |
8/14/2019, 03:53 PM |
Q1 2019 |
136 |
$417M |
+$27.9M |
-$17.6M |
+$10.3M |
AMZN, AVGO, TSM, ENB, CME
|
13F-HR |
5/15/2019, 03:30 PM |
Q4 2018 |
129 |
$369M |
+$100M |
-$6.15M |
+$93.9M |
CME, AMZN, AVGO, TSM, ENB
|
13F-HR |
2/14/2019, 02:00 PM |
Q3 2018 |
127 |
$320M |
+$5.98M |
-$202M |
-$196M |
AMZN, TSM, CME, MSFT, META
|
13F-HR |
11/14/2018, 02:44 PM |
Q2 2018 |
175 |
$572M |
+$28.3M |
-$26.9M |
+$1.42M |
AMZN, CME, MSFT, TSM, META
|
13F-HR |
8/14/2018, 04:11 PM |
Q1 2018 |
173 |
$558M |
+$87.9M |
-$34.1M |
+$53.8M |
AMZN, CME, TSM, MSFT, META
|
13F-HR |
5/15/2018, 04:33 PM |
Q4 2017 |
153 |
$527M |
+$104M |
-$1.12B |
-$1.02B |
AMZN, TSM, CME, MSFT, ENB
|
13F-HR |
2/14/2018, 01:04 PM |
Q3 2017 |
111 |
$1.52B |
+$112M |
-$98.7M |
+$13.3M |
MSFT, TSM, INCY, CME, V
|
13F-HR |
11/14/2017, 04:13 PM |
Q2 2017 |
114 |
$1.51B |
+$80.8M |
-$108M |
-$27.5M |
MSFT, TSM, INCY, CME, V
|
13F-HR |
8/14/2017, 02:46 PM |
Q1 2017 |
114 |
$1.54B |
+$83.6M |
-$49.5M |
+$34M |
MSFT, INCY, TSM, CME, V
|
13F-HR |
5/15/2017, 04:04 PM |
Q4 2016 |
121 |
$1.43B |
+$313M |
-$62.2M |
+$251M |
MSFT, TSM, CME, INCY, V
|
13F-HR |
2/15/2017, 06:41 AM |
Q3 2016 |
139 |
$1.42B |
+$48.7M |
-$90.8M |
-$42.1M |
MSFT, TSM, CME, INCY, V
|
13F-HR |
11/14/2016, 04:32 PM |
Q2 2016 |
138 |
$1.38B |
+$63.7M |
-$187M |
-$124M |
MSFT, TSM, CME, INCY, DHR
|
13F-HR |
8/15/2016, 04:57 PM |
Q1 2016 |
185 |
$1.55B |
+$107M |
-$76.2M |
+$30.9M |
MSFT, GS, CME, TSM, INCY
|
13F-HR |
5/16/2016, 02:12 PM |
Q4 2015 |
186 |
$1.58B |
+$162M |
-$85.6M |
+$76.3M |
MSFT, GS, INCY, CME, TSM
|
13F-HR |
2/12/2016, 01:58 PM |
Q3 2015 |
183 |
$1.51B |
+$159M |
-$78.2M |
+$80.4M |
GS, INCY, MSFT, CME, NWL
|
13F-HR |
11/16/2015, 03:25 PM |
Q2 2015 |
1 |
$21.9M |
|
|
|
GOOGXXXX
|
New Holdings |
9/16/2015, 06:39 PM |
Q2 2015 |
192 |
$1.7B |
+$169M |
-$130M |
+$39.1M |
GS, MSFT, INCY, GILD, CME
|
13F-HR |
8/14/2015, 04:10 PM |
Q1 2015 |
178 |
$1.64B |
+$172M |
-$124M |
+$48.6M |
GS, MSFT, INCY, BMY, CME
|
13F-HR |
5/15/2015, 05:15 PM |
Q4 2014 |
5 |
$30.8M |
|
|
|
GOOGXXXX, SGENXXXX, LEG, COH, MR
|
New Holdings |
2/27/2015, 07:08 PM |
Q4 2014 |
174 |
$1.61B |
+$247M |
-$219M |
+$28.1M |
GS, CVX, GILD, BMY, MSFT
|
Restatement |
2/27/2015, 07:07 PM |
Q3 2014 |
170 |
$1.61B |
+$99.7M |
-$97.9M |
+$1.79M |
GILD, GS, CVX, BMY, AAPL
|
13F-HR |
11/14/2014, 01:27 PM |
Q2 2014 |
176 |
$1.62B |
+$180M |
-$158M |
+$22.5M |
GILD, CVX, GS, BMY, AAPL
|
13F-HR |
8/14/2014, 02:02 PM |
Q1 2014 |
165 |
$1.6B |
+$97.9M |
-$74.5M |
+$23.4M |
GILD, BMY, GS, GOOGLXXXX, DHR
|
13F-HR |
5/15/2014, 02:27 PM |
Q4 2013 |
161 |
$1.64B |
|
|
|
GILD, GS, BMY, GOOGLXXXX, VRSN
|
13F-HR |
2/14/2014, 12:30 PM |